Vium
Vium is a biotechnology company that develops digital biomarkers to transform preclinical research and animal welfare. It is fully accredited by AAALAC International and received an unprecedented AAALAC commendation for upholding the 3 Rs, the gold-standard framework for humane animal research. Customers run the spectrum of biotechnology, pharmaceutical, and computational drug discovery companies to academia and novel therapeutic labs. Vium's digital platform provides physiological biomarkers that enable better decisions on which compounds should be advanced to the clinic. The company's platform Digital Vivariumand Vium Cloud is the gold-standard in vivo platform combining computer vision, artificial intelligence, machine learning, and sensor technology to non-invasively collect and derive insights from digital biomarkers. The platform continuously captures physiological metrics and behaviors non-invasively, providing more sensitive and accurate data collection, leading to more replicable studies. Vium was founded in 2013 and is headquartered in San Mateo, California, United States.
Vium
Vium is a biotechnology company that develops digital biomarkers to transform preclinical research and animal welfare. It is fully accredited by AAALAC International and received an unprecedented AAALAC commendation for upholding the 3 Rs, the gold-standard framework for humane animal research. Customers run the spectrum of biotechnology, pharmaceutical, and computational drug discovery companies to academia and novel therapeutic labs. Vium's digital platform provides physiological biomarkers that enable better decisions on which compounds should be advanced to the clinic. The company's platform Digital Vivariumand Vium Cloud is the gold-standard in vivo platform combining computer vision, artificial intelligence, machine learning, and sensor technology to non-invasively collect and derive insights from digital biomarkers. The platform continuously captures physiological metrics and behaviors non-invasively, providing more sensitive and accurate data collection, leading to more replicable studies. Vium was founded in 2013 and is headquartered in San Mateo, California, United States.
TL;DR
Founded: 2013
Headquarters: San Mateo, California, United States
Product: Digital Vivarium / Vium Cloud (non‑invasive digital biomarkers)
Acquisition status: Acquired by Recursion Pharmaceuticals (announcement July 2020)
Latest disclosed round: Series B (closed June 2018)
Company Overview
Problem Domain
Preclinical research data quality and animal welfare (digital biomarker collection and analysis).
Founded
2013
Industry
Biotechnology
Tech Stack
Funding Track Record
Series B closed June 2018; sources list DCVC and Lux Capital as lead investors.
Investor Signal
“Venture‑backed (investors reported include Lux Capital, DCVC, Founders Fund, Proteus Digital Health, Female Founders Fund, Dolby Family Ventures)”